
Lasa Supergenerics Hits Lower Circuit Amid Heavy Selling Pressure
2025-11-24 15:00:09Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 24 Nov 2025 as it hit its lower circuit limit, reflecting intense selling pressure and a significant daily loss that outpaced both its sector and the broader market indices.
Read More
Lasa Supergenerics Faces Intense Selling Pressure Amid Prolonged Downtrend
2025-11-24 14:21:03Lasa Supergenerics Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.91% today and exhibiting a complete absence of buyers. This extreme selling activity reflects distress signals as the pharmaceutical company continues to underperform against broader market indices and its sector peers.
Read MoreWhy is Lasa Supergeneri falling/rising?
2025-11-19 23:35:31As of 19-Nov, Lasa Supergenerics Ltd is currently priced at 10.27, reflecting a slight increase of 0.02 (0.2%). The stock has experienced a trend reversal, gaining after four consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume on 18 Nov falling by 91.48% compared to the 5-day average. The stock has underperformed in the longer term, with a year-to-date decline of 60.26% and a 5-year decline of 86.66%, which suggests ongoing challenges despite today's minor uptick. In the broader market context, Lasa Supergenerics' short-term performance has been notably poor compared to the benchmark Sensex, which has gained 0.85% over the past week while Lasa has declined by 6.47%. This stark contrast highlights the stoc...
Read More
Lasa Supergenerics Ltd Stock Hits Upper Circuit Limit with Intraday High of Rs 10.76
2025-11-17 11:00:18Lasa Supergenerics Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, reached its upper circuit limit today, with a notable increase in investor participation. The stock's trading volume surged significantly, reflecting strong market activity despite being below its moving averages across various time frames.
Read MoreHow has been the historical performance of Lasa Supergeneri?
2025-11-15 00:12:35Answer: The historical performance of Lasa Supergeneri shows significant fluctuations in key financial metrics over the years. Breakdown: Lasa Supergeneri's net sales have varied, peaking at 202.38 Cr in March 2021 but declining to 142.45 Cr by March 2025, with a notable drop from 137.13 Cr in March 2022. Total operating income followed a similar trend, reflecting the same values as net sales. Raw material costs increased to 108.10 Cr in March 2025 from 79.28 Cr in March 2024, while total expenditure rose to 136.18 Cr in March 2025, indicating rising operational costs. Operating profit, which was positive at 47.22 Cr in March 2021, turned negative in March 2023 at -6.59 Cr and improved to 6.27 Cr by March 2025. Profit before tax remained negative, reaching -19.38 Cr in March 2025, with profit after tax also negative at -14.76 Cr. The company's equity capital remained stable at 50.10 Cr from March 2023 to M...
Read MoreWhy is Lasa Supergeneri falling/rising?
2025-11-11 23:23:57As of 11-Nov, Lasa Supergenerics Ltd is experiencing a decline in its stock price, currently at 10.76, which reflects a decrease of 0.56 or 4.95%. The stock has been underperforming significantly, with a consecutive fall over the last five days resulting in an overall drop of 8.03%. It is trading below all key moving averages, indicating a bearish trend. Additionally, investor participation has decreased sharply, with delivery volume falling by 80.49% compared to the five-day average. The stock has also shown poor performance over various periods, with year-to-date returns down by 58.36% and a staggering 86.07% decline over the past five years. In the broader market context, Lasa Supergenerics Ltd's recent performance contrasts sharply with the Sensex, which has gained 7.34% year-to-date. Over the past week, while the Sensex has increased by 0.49%, Lasa Supergenerics has declined by 7.88%, highlighting its...
Read More
Lasa Supergenerics Ltd Hits Lower Circuit Limit with Low Price of Rs 11.02
2025-11-03 11:00:18Lasa Supergenerics Ltd faced significant trading activity today, hitting its lower circuit limit with a notable decline. The stock's performance was below the sector average, and investor participation decreased sharply. Despite remaining above several moving averages, it traded below its 200-day moving average, indicating a shift in market sentiment.
Read MoreWhy is Lasa Supergeneri falling/rising?
2025-10-30 23:06:41As of 30-Oct, Lasa Supergenerics Ltd is experiencing a price increase, currently at 11.80, reflecting a change of 0.29 or 2.52% upward. The stock has shown a strong performance recently, gaining 9.46% over the last four days and outperforming its sector by 2.86% today. Additionally, the stock's delivery volume has significantly increased by 245.17% compared to the 5-day average, indicating rising investor participation. Despite a year-to-date decline of 54.33% and a 1-year drop of 54.62%, the recent upward trend suggests a potential recovery phase, although no specific positive or negative factors were provided to further explain this movement. In the broader market context, Lasa Supergenerics Ltd's short-term return of 7.08% over the past week contrasts sharply with the Sensex, which has decreased by 0.18% during the same period. This indicates that the stock is performing well relative to the overall mar...
Read More
Lasa Supergenerics Ltd Rises 4.91% Today, Surpassing Sensex Amid Strong Buying Activity
2025-10-29 15:16:04Lasa Supergenerics Ltd is experiencing notable buying activity, with a 4.91% increase today, outperforming the Sensex. The stock has gained 8.16% over the past week, marking three consecutive days of gains. However, its longer-term performance shows a significant decline over the past year.
Read MoreRelated Party Trasnaction As 30.09.2025
14-Nov-2025 | Source : BSERelated party transaction as on 30.09.2025
Results As On 30 Th Septemer 2025
14-Nov-2025 | Source : BSEResults as on 30.09.2025
Integrated Filing September 30 2025
14-Nov-2025 | Source : BSEIntegrated filing September 30 2025
Corporate Actions
No Upcoming Board Meetings
Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22
No Splits history available
No Bonus history available
No Rights history available






